Case Studies, Pharmaceutical

Case Study – Unidose Nasal Spray Pump in Hypoglycemia

The conventional rescue medicine for hypoglycemia is an intramuscular injection of glucagon which must be reconstituted at point of use. This case study describes a collaborative drug repurposing project with Aptar Pharma culminating in the development of a glucagon nasal powder, an easier to administer alternative. The product utilizes Aptar Pharma’s patented Unidose Powder (UDS) device, is easy-to-store, and has a shelf-life of two years from manufacture. It provides diabetes patients with a highly effective rescue medicine that can be administered by a range of potential carers. Success rates with the nasal powder have been shown to exceed those with injectable glucagon and the product’s market value is expected to exceed $150 million by 2025.

Download Case Study - Unidose Nasal Spray pump in hypoglycemia
8 Sep 2022

Learn more about Aptar Pharma Expertise
in Nasal Drug Delivery

Find Out More About nasal drug delivery expertise

This Might Also Be of Interest

25 May 2023

Exploring the Benefits and Future Possibilities of Nasal Drug Delivery and Drug Repos...

Webinars, Pharmaceutical, Market Insights, Product Solutions, Device Innovations, Brand Differentiation

Read More
11 May 2023

Why Pharma should care about circular packaging – Futurity leading the way

Publications, Pharmaceutical, Brand Differentiation, Product Solutions, Sustainability, Device Innovations

Read More
10 May 2023

Navigating the Development for Orally Inhaled and Nasal Drug Products

Publications, Pharmaceutical, Product Solutions, Device Innovations, Market Insights

Read More
2 May 2023

Using Intranasal Delivery for Drug Repositioning: A Compelling Proposition for Lifecy...

Publications, Pharmaceutical, Brand Differentiation, Market Insights, Product Solutions, Device Innovations

Read More
1 2 3 20

Request Access


Requesting access to Case Study – Unidose Nasal Spray Pump in Hypoglycemia.

  • This field is for validation purposes and should be left unchanged.
Back To Top